Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (431-440 of 1,623) with videos related to

Pageof 163
Sort By:
Current Oncology Reports|September 10, 2008
Diagnostic evaluations of unproven clinical utility in oncology: a real-life example of their harmful consequencesMaurie Markman
Oncology|November 1, 2007
Increasing entry of the elderly into cancer clinical trials: difficult, but unquestionably necessaryMaurie Markman
Gynecologic Oncology|August 7, 2008
The remarkable "paclitaxel story": how many chapters remain to be written?Maurie Markman
Current Oncology Reports|August 19, 2008
Risk of toxicity versus risk of death: a complex equation in the management of highly curable malignanciesMaurie Markman
Cancer Treatment and Research|July 18, 2007
Current status of intraperitoneal antineoplastic drug deliveryM Markman
Gynecologic Oncology|January 30, 2009
Hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer: A critical need for an evidence-based evaluationMaurie Markman
Gynecologic Oncology|January 14, 2009
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancerMaurie Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
85th annual meeting of the American Association for Cancer Research. San Francisco, California, April 1994M Markman
Journal of the American Dental Association (1939)|March 31, 2020
More on second opinionsStanley Markman
Journal of the New Jersey Dental Association|August 22, 2014
Referred painStanley Markman
Pageof 163

Showing results (431-440 of 1,623) with videos related to

Sort By:
Pageof 163
Current Oncology Reports|September 10, 2008
Diagnostic evaluations of unproven clinical utility in oncology: a real-life example of their harmful consequencesMaurie Markman
Oncology|November 1, 2007
Increasing entry of the elderly into cancer clinical trials: difficult, but unquestionably necessaryMaurie Markman
Gynecologic Oncology|August 7, 2008
The remarkable "paclitaxel story": how many chapters remain to be written?Maurie Markman
Current Oncology Reports|August 19, 2008
Risk of toxicity versus risk of death: a complex equation in the management of highly curable malignanciesMaurie Markman
Cancer Treatment and Research|July 18, 2007
Current status of intraperitoneal antineoplastic drug deliveryM Markman
Gynecologic Oncology|January 30, 2009
Hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer: A critical need for an evidence-based evaluationMaurie Markman
Gynecologic Oncology|January 14, 2009
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancerMaurie Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
85th annual meeting of the American Association for Cancer Research. San Francisco, California, April 1994M Markman
Journal of the American Dental Association (1939)|March 31, 2020
More on second opinionsStanley Markman
Journal of the New Jersey Dental Association|August 22, 2014
Referred painStanley Markman
Pageof 163